Course offering number:1003-407
Course ID:
448
INDs/NDAs/CTDs
March 22-24, 2010
Burlingame, CA
This course is currently unavailable for online registration. Please contact Customer Service at 732.613.4500 or info@cfpa.com for more information.
Who Should Attend
This course is directed to personnel involved in:
• New Pharmaceutical Product Development
• Pre-clinical and Clinical Research
• Regulatory Affairs
• Quality Assurance
Participants should have an understanding of the steps in new
product development and/or the responsibilities of regulatory
affairs in submitting new product applications worldwide.
Description
The content of this course is to present detailed components
of INDs/NDAs, BLAs, ANDAs, SNDAs, IMPDs and CTDs
(Modules 1–5). These regulatory submissions will be based
on the requirements of the US Code of Federal Regulations,
EU Directives and ICH guidelines. Each of these regulatory
documents will be presented as they are related to safety,
quality and efficacy necessary for global submissions. Details
of non and pre-clinical data, clinical data, and CMC data
necessary to achieve new product approvals globally will be
presented and discussed. Recommendations for expediting
new product approvals will be correlated with the regulatory
procedures.
Other topics presented that will help participants understand
the structure and bureaucratic demands will include:
• FDAs internal structure, policies and procedures
• Regulation requirements for new product submissions
including SNDAs, CTDs and DMFs globally
• Acceptance of international data for use in new product
approvals
• Similarities between EU directives and FDAs Code of
Federal Regulations and ICH guidelines
Other Courses of Interest
Best Practices in SAS Statistical Programming for Regulatory Submission
Biosafety of Biological Drug Products
CMC Submissions in CTD Format
Apr 26 2010, New Brunswick, NJ
Developing Specifications for Drug Substances (APIs) and Drug Products
Early Stage Clinical Studies for Drugs and Devices
Generic Drug Approvals
May 03 2010, New Brunswick, NJ
Non-Clinical Drug Safety Evaluation and Drug Development
Mar 15 2010, New Brunswick, NJ
Preparation, Packaging and Labeling of Clinical Trial Materials
Jun 07 2010, New Brunswick, NJ
Preparation, Packaging and Labeling of Clinical Trial Materials
Jul 07 2010, Amsterdam, The Netherlands
Related Industries